Thursday, September 29, 2011

J&J Buys Merck’s Share of OTC Drug Partnership for $175 Million - Businessweek

Sept. 28 (Bloomberg) -- Johnson & Johnson bought Merck & Co.’s half of the companies’ joint venture for over-the-counter medicines for heartburn and digestive diseases for $175 million, ending a 22-year partnership in the U.S. and Canada.

The deal announced today includes a manufacturing plant in Lancaster, Pennsylvania, that is part of a consent decree with U.S. regulators because of production violations. J&J, the world’s second-biggest seller of health products after Pfizer Inc., has recalled dozens of drugs and devices in the past two years, including nonprescription medicines such as Tylenol.

Posted via email from Jack's posterous

1 comment:

pharmajobs UK said...

The deal announced today includes a manufacturing plant in Lancaster, Pennsylvania, that is part of a consent decree with U.S. regulators because of production violations.